Host: Jason Freeman, MD, MBA

Guest: Scott Zamvil, MD, PhD

Our understanding of immunoglobins’ role in multiple sclerosis (MS) has evolved over the years. Joining Dr. Jason Freeman to share what we currently know about immunoglobins and immunology considerations for MS therapies and patient case scenarios is Dr. Scott Zamvil, Professor of Neurology and Faculty Member in the Program in Immunology at the University of California, San Francisco.

9/21 152858